tiprankstipranks
Trending News
More News >
Physiomics PLC (GB:PYC)
LSE:PYC
Advertisement

Physiomics PLC

Compare
3 Followers

PYC Stock Chart & Stats

0.42p
0.05p(6.45%)
At close: 4:00 PM EST
0.42p
0.05p(6.45%)

Physiomics News

PYC FAQ

What was Physiomics PLC’s price range in the past 12 months?
Physiomics PLC lowest share price was 0.38p and its highest was 1.40p in the past 12 months.
    What is Physiomics PLC’s market cap?
    Physiomics PLC’s market cap is £1.29M.
      When is Physiomics PLC’s upcoming earnings report date?
      Physiomics PLC’s upcoming earnings report date is Mar 10, 2026 which is in 128 days.
        How were Physiomics PLC’s earnings last quarter?
        Physiomics PLC released its earnings results on Sep 29, 2025. The company reported -0.001p earnings per share for the quarter, missing the consensus estimate of N/A by -0.001p.
          Is Physiomics PLC overvalued?
          According to Wall Street analysts Physiomics PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Physiomics PLC pay dividends?
            Physiomics PLC does not currently pay dividends.
            What is Physiomics PLC’s EPS estimate?
            Physiomics PLC’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Physiomics PLC have?
            Physiomics PLC has 303,208,700 shares outstanding.
              What happened to Physiomics PLC’s price movement after its last earnings report?
              Physiomics PLC reported an EPS of -0.001p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.167%.
                Which hedge fund is a major shareholder of Physiomics PLC?
                Currently, no hedge funds are holding shares in GB:PYC

                Company Description

                Physiomics PLC

                Physiomics (PYC) is a healthcare and technology company specializing in the application of computational systems biology to improve drug development processes. It operates primarily in the biotechnology and pharmaceutical sectors, offering cutting-edge modeling and simulation services to optimize clinical trial designs and enhance drug development efficiency. Core services include Virtual Tumor technology and other predictive modeling tools that support decision-making in oncology drug development.

                Physiomics (PYC) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Evgen Pharma
                Nuformix Plc
                Cizzle Biotechnology Holdings PLC
                ValiRx plc

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis